Olamide
Nigerian rapper, singer, songwriter, and record executive
Olamide Gbenga Adedeji (; born 15 March 1989), known mononymously as Olamide, is a Nigerian rapper, singer, songwriter, and record executive. Olamide, who is regarded as one of the most influential artists in Nigeria and Africa, has been crucial to the creative and commercial success of several Afrobeats music stars. He records in Yoruba and English. In 2011, he released his debut studio album, Rapsodi, while signed to ID Cabasa's Coded Tunes. YBNL, his follow-up album, was released under his label imprint "Yahoo Boy No Laptop", also known as YBNL Nation. The album was supported by the singles "First of All", "Voice of the Street", "Stupid Love", and "Ilefo Illuminati". On 7 November 2013, he released his third studio album, Baddest Guy Ever Liveth. The album's singles include Durosoke" and "Yemi My Lover". On 17 July 2013, Olamide became the first Nigerian to sign an endorsement deal with Cîroc.
In November 2023, he received his first nomination at the 66th Annual Grammy Awards for the song "Amapiano" alongside his signee Asake making him one of the first Nigerian and African rappers to be recognised in that category.
The public source identifies “Olamide” as nigerian rapper, singer, songwriter, and record executive. This brief keeps that definition visible, then builds a research path around Olamide, Nigerian and rapper.
Why this record matters
A short description can identify a subject without explaining its stakes. For “Olamide”, the useful work is to connect “nigerian rapper, singer, songwriter, and record executive” to the records capable of establishing context and consequence.
Chronology provides the most reliable spine for this subject; interpretation should follow only after identities and dates are secure. The source revision retrieved here is dated Sep 24, 2026. The linked authority identifier is Q16221097. VIAF identifies the subject as 160164422988220530003. The Library of Congress control number is no2017099446. 1 of 3 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 1989, 2011, 2013 and 2023.
Public reputation and documentary evidence do not always develop together; absence from a summary is not evidence of historical absence. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Read biographical claims against dates, named institutions and the cited references. Distinguish a subject’s later reputation from evidence produced during their lifetime.
- Establishing names and roles
- Building a first chronology
- Locating cited institutions
Personal papers, civil or court records, institutional files and the scholarship cited by the source.
Three-step research path
- Establish the record: confirm the title “Olamide”, its source revision and the description used here.
- Expand the search: follow Olamide primary sources, Olamide archive and Olamide research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Olamide”?
- Which primary records establish identity, chronology and institutional ties?
- Which claims depend on a single source or contested interpretation?
Search terms from this dossier
This entry incorporates text from “Olamide” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.